Research Translation
Screening Tools to Assess Incarcerated Women for Opioid Use Disorder
Findings from JCOIN’s Kentucky Research Hub Rates of incarceration of women rose 475% from 1980 to 2020, largely driven by drug-related charges, yet many barriers exist to the provision of substance use disorder (SUD) treatment services for women in correctional facilities, including SUD diagnostic assessments. A new study led by Drs. Michele Staton, Martha Tillson,…
Read More15 Key Buprenorphine Dosing Recommendations for Jail-Based Treatment Programs
Findings from JCOIN’s Massachusetts Clinical Research Center Medication for opioid use disorder (MOUD) (e.g., buprenorphine) is an evidence-based treatment for opioid use disorder (OUD). While dispensing buprenorphine in correctional settings has become a more common practice, corrections staff cite MOUD diversion as a reason for not offering the medications in jails and prisons. In a…
Read MoreSix Strategies to Prevent MOUD Diversion in Jail-Based Treatment Programs
Read more Findings from JCOIN’s Massachusetts Clinical Research Center Diversion of medication for opioid use disorder (MOUD) treatment is often cited as a concern and a reason for not offering the medications in jails and prisons. Researchers from the University of Massachusetts published a study in 2023 that detailed promising practices in program design to…
Read MoreNew Study on Distribution of Federal Funding Across States to Address the Opioid Crisis in Justice Settings
Findings from JCOIN’s Coordination and Translation Center (CTC) and Methodology and Advanced Analytics Resource Center (MAARC) A new study published in the Journal of Substance Use and Addiction Treatment (JSAT) found that more than $590 million was allocated to states across 517 grants by 10 federal agencies to address the intersection of OUD and the…
Read MoreContinuous Trainings on Behavioral Therapies May Help Address Implementation and Delivery Barriers of Effective SUD Treatments
JCOIN Spotlight: Findings from JCOIN’s Indiana University School of Medicine Clinical Research Center Ongoing training on evidence-based practices for substance use disorders (SUD) shows promise in increasing confidence among therapists in applying such services in community-based settings, according to recent study findings. In turn, dissemination and implementation initiatives that provide ongoing training could improve the…
Read MoreHHS Releases New Medicaid Reentry 1115 Demonstration Opportunity to Increase Access to Care for Individuals Leaving Prison and Jail
On April 17, 2023, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), released new guidance that allows states to utilize Medicaid funds to provide health care services to incarcerated individuals, including substance use disorder treatment. The new Medicaid Reentry Section 1115 Demonstration Opportunity would provide states…
Read MoreStudy Identifies Key Barriers and Facilitators for Medications to Treat Opioid Use Disorders in U.S. Jails
Download the Fact Sheet (PDF) Findings from JCOIN’s Chestnut Health Systems Clinical Research Center Transitioning to the community following incarceration is a particularly high risk for individuals with opioid use disorder (OUD), especially during the first two weeks of release. Substantial evidence shows that initiating medications for opioid use disorder (MOUD) during incarceration and continuation…
Read MoreResearch Finds that Brief Interventions Can Correct Officer Perceptions of the Harms of Accidental Fentanyl Contact among First Responders
Misinformation about the risk of overdose from accidentally inhaling or touching fentanyl is common among first responders and the general public in the United States. While the risk is very low, and there has never been a confirmed case, officers consistently report that they are at great risk from overdose through accidental contact in the…
Read MoreExtended Release Buprenorphine in Correctional Settings Shows Increased Treatment Retention and Reduced Opioid Use
Findings from JCOIN’s New York University Research Hub Both the rate of opioid use and the rate of overdose following release from jail or prison are disproportionately high in justice-involved populations [1]. Although medications for opioid use disorder (MOUD) are proven to reduce the likelihood for post-release overdose, they are largely underutilized in correctional…
Read MoreVideo Explainer: Extended-Release Buprenorphine in Correctional Settings
A recent study published in the Journal of the American Medical Association (JAMA) found improved treatment outcomes for individuals prescribed extended-release buprenorphine in jail settings. Learn more in the short video below.
Read More